Cadrenal Therapeutics Inc — Balance Sheet (NASDAQ:CVKD)

Financials

Total assets 778.17 K8.52 M10.12 M4.33 M Total liabilities 6.33 M826.88 K2.68 M1.59 M Total equity -5.55 M7.69 M7.44 M2.74 M Total liabilities & shareholders' equities 778.17 K8.52 M10.12 M4.33 M Total debt 1.15 M0—— Net debt 1.12 M-8.4 M——

News

Cadrenal schedules FDA meeting for HIT drug CAD-1005

Cadrenal Therapeutics stock surges on Phase 2 trial results

Cadrenal’s CAD-1005 shows reduction in blood clots in HIT trial

Cadrenal highlights potential of 12-LOX inhibitor for blood disorder

Cadrenal Therapeutics acquires first-in-class HIT treatment from Veralox

Cadrenal Therapeutics appoints PTC Therapeutics CMO to board

Cadrenal Therapeutics, Inc.

Cadrenal therapeutics CFO Szot sells $1496 in shares

Szot, CFO of Cadrenal, sells $174k in CVKD stock

Cadrenal therapeutics (CVKD) CEO Pham sells $131,779 in stock

Cadrenal Therapeutics acquires eXIthera’s anticoagulant portfolio